Association between Angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: A meta analysis

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 6291-6300

  Zhang, Kan ^a,b   Cheng, Dan ^a,b   Yi, Lingling ^a,b   Shi, Huimin ^a,b   Zhen, Guohua ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Key Laboratory of Respiratory Diseases National Health and Family Planning Commission of the People's Republic of China   (China)

Author keywords

ACE I D; Cancer risk; Meta analysis; Single nucleotide polymorphism

Indexed keywords

ACE PROTEIN, HUMAN; DIPEPTIDYL CARBOXYPEPTIDASE;

CASE CONTROL STUDY; CAUCASIAN; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; NEOPLASM; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84911925158     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Stroth U, Unger T. The renin angiotensin system and its receptors. J Cardiovasc Pharmacol 1999; S41-43.
2. Murphey LJ, Gainer JV, Vaughan DE and Brown NJ. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000; 102: 829-832.
3. Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005; 16: 293-299.
4. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T and Imaizumi T. Role of host angiotensin II type 1 receptor in angiogenesis and growth. J Clin Invest 2003; 112: 67-75.
5. Kaufman KM, Kelly J, Gray-McGuire C, Asundi N, Yu H, Reid J, Baird T, Hutchings D, Bruner G, Scofield RH, Moser K and Harley JB. Linkage insertion/deletion polymorphism and systemic lupus erythematosus. Mol Cell Endocrinol 2001; 177: 81-85.
6. Abali H, Gullu IH, Engin H, Haznedaroğlu IC, Erman M and Tekuzman G. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Med Hypotheses 2002; 59: 344-348.
7. Yoshiji H, Kuriyama S and Fukui H. Angiotensin- I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 2002; 23: 348-356.
8. Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 2004; 23: 317-329.
9. Carl-McGrath S, Lendeckel U, Ebert M, Wolter AB, Roessner A and Röcken C. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol 2004; 25: 1223-1232.
10. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL and Robertson JW. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998; 352: 179-184.
11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
12. Winkelmann BR, Nauck M, Klein B, Russ AP, Böhm BO, Siekmeier R, Ihnken K, Verho M, Gross W and März W. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996; 125: 19-25.
13. Rocken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, Kruger S, Malfertheiner P, Roessner A and Ebert MP. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 2005; 11: 2526-2530.
14. Analysis of Longitudinal Data. 2nd ed. In: Oxford University Press, Diggle Peter J, Heagerty Patrick, Liang Kung-Yee and Zeger Scott L, editors. Oxford University Press; 2002. pp. 169-171.
15. Applied Longitudinal Analysis. In: Hoboken JWS, Fitzmaurice GM, Laird NM and Ware JH, editors. Hoboken: John Wiley & Sons; 2004. pp. 326-328.
16. Laird NM, Ware JH. Random-Effects Models for Longitudinal Data. Biometrics 1982; 38: 963-974.
17. Munafo MR, Clark TG and Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 2004; 129: 39-44.
18. Zhang YG, Huang J, Zhang J, Li XB, He C, Xiao YL, Tian C, Wan H, Zhao YL, Tsewang YG and Fan H. RANTES gene polymorphisms and asthma risk: a meta-analysis. Arch Med Res 2010; 41: 50-58.
19. Yaren A, Turgut S, Kursunluoglu R, Oztop I, Turgut G, Degirmencioglu S, Kelten C, Erdem E. Insertion/Deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors. J Investig Med 2007; 55: 255-261.
20. Namazi S, Monabati A, Ardeshir-Rouhani-Fard S, Azarpira N. Association of angiotensin I converting enzyme (Insertion/Deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian population. Mol Carcinog 2010; 49: 1022-1030.
21. Gonzalez-Zuloeta Ladd AM, Vasquez AA, Sayed-Tabatabaei FA, Coebergh JW, Hofman A, Njajou O, Stricker B and van Duijn C. Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 2143-2146.
22. Vairaktaris E, Yapijakis C, Tsigris C, Vassiliou S, Derka S, Nkenke E, Spyridonidou S, Vylliotis A, Vorris E, Ragos V, Neukam FW and Patsouris E. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 2007; 6: 1097-1102.
23. Liu SY, Sima X, Wang CH and Gao M. The association between ACE polymorphism and risk of colorectal cancer in a Chinese population. Clin Biochem 2011; 44: 1223-1226.
24. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H and Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006; 15: 1929-1934.
25. van der Knaap R, Siemes C, Coebergh JW, van Duijn CM, Hofman A and Stricker BH. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam study. Cancer 2008; 112: 748-757.
26. Nacak M, Nacak I, Sanli M, Ozkur M, Pektaş M and Aynacioğlu AS. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. Cancer Genet Cytogenet 2010; 198: 22-26.
27. Nikiteas N, Tsigris C, Chatzitheofylaktou A and Yannopoulos A. No Association with risk for colorectal cancer of the insertion/deletion polymorphism which affects levels of angiotensin-converting enzyme. In Vivo 2007; 21: 1065-1068.
28. Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Juozaityte E, Kiudelis G, Jonaitis L and Malfertheiner P. Lack of association between gene polymorphismsof angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Med Genet 2011; 12: 112.
29. Yaren A, Turgut S, Kursunluoglu R, Oztop I, Turgut G, Kelten C and Erdem E. Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J Exp Med 2006; 210: 109-116.
30. Usmani BA, Janeczko M, Shen R, Mazumdar M, Papandreou CN and Nanus DM. Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer. Br J Cancer 2000; 82: 550-552.
31. Yigit B, Bozkurt N, Narter F, Yilmaz H, Yucebas E and Isbir T. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer Res 2007; 27: 933-936.
32. Koh WP, Yuan JM, Sun CL, van den Berg D, Seow A, Lee HP and Yu MC. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003; 63: 573-578.
33. Srivastava K, Srivastava A and Mittal B. Angiotensin I-converting enzyme insertion/deletion polymorphism and increased risk of gall bladder cancer in women. DNA Cell Biol 2010; 29: 417-422.
34. Yuan F, Zhang LS, Li HY, Liao M, Lv M and Zhang C. Influence of Angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China. DNA Cell Biol 2013; 32: 268-273.
35. Yaren A, Oztop I, Turgut S, Turgut G, Degirmencioglu S and Demirpence M. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Exp Biol Med (Maywood) 2008; 233: 32-37.
36. Alves Corrêa SA, Ribeiro de Noronha SM, Nogueira-de-Souza NC, Valleta de Carvalho C, Massad Costa AM, Juvenal Linhares J, Vieira Gomes MT and Guerreiro da Silva ID. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst 2009; 10: 51-58.
37. Gao M, Wang Y, Shi Y, Liu D, Liang Y, Yu Y, Zhaobin J, Zhu L and Jin S. The relationship between three well-characterized polymorphisms of the angiotensin converting enzyme gene and lung cancer risk: a case-control study and a meta-analysis. J Renin Angiotensin Aldosterone Syst 2012; 13: 455-460.
38. Lukic S, Nikolic A, Alempijevic T, Popovic D, Sokic Milutinovic A, Ugljesic M, Knezevic S, Milicic B, Dinic D and Radojkovic D. Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer. Dig Surg 2011; 28: 258-262.
39. Goto Y, Ando T, Nishio K, Ishida Y, Kawai S, Goto H and Hamajima N. The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 2005; 6: 464-467.
40. Toma M, Cimponeriu D, Apostol P, Stavarachi M, Cojocaru M, Belusică L, Crăciun AM, Radu I and Gavrilă L. Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients. Chirurgia (Bucur) 2009; 104: 553-556.
41. Haiman CA, Henderson SO, Bretsky P, Kolonel LN and Henderson BE. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 2003; 63: 6984-6987.
42. Li ZH, Pan XM, Han BW, Han HB, Zhang Z and Gao LB. No association between ACE polymorphism and risk of nasopharyngeal carcinoma. J Renin Angiotensin Aldosterone Syst 2012; 13: 210-215.
43. Mendizábal-Ruiz AP, Morales J, Castro Martinez X, Gutierrez Rubio SA, Valdez L, Vásquez-Camacho JG, Sanchez Corona J and Moran Moguel MC. RAS polymorphisms in cancerous and benign breast tissue. J Renin Angiotensin Aldosterone Syst 2011; 12: 85-92.
44. Cheon KT, Choi KH, Lee HB, Park SK, Rhee YK and Lee YC. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000; 178: 351-360.
45. Ding XJ. Analysis of the relationship between the polymorphism of angiotensin-converting enzyme gene and lung cancer (Chinese). 2008.
46. Holla L, Vasku A, Soucek M, Krahulcova E, Hajek D and Znojil V. Angiotensin-converting enzyme gene polymorphism and blood groups of the ABO system in Leukaemias compared with controls and hypertensives. Scripta Medica (Brno) 1998; 71: 471-477.
47. Röcken C, Neumann K, Carl-McGrath S, Lage H, Ebert MP, Dierkes J, Jacobi CA, Kalmuk S, Neuhaus P and Neumann U. The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia 2007; 9: 716-722.
48. Tunny TJ, Xu L, Richardson KA, Stowasser M, Gartside M and Gordon RD. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma. J Hum Hypertens 1996; 10: 827-830.
49. Ozen F, Polat F, Arslan S and Ozdemir O. Combined germline variations of thrombophilic genes promote genesis of lung cancer. Asian Pac J Cancer Prev 2013; 14: 5449-5454.
50. Vaskù V, Vaskù JA, Goldbergová MP and Vaskù A. Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma. Acta Dermatovenerol Alp Panonica Adriat 2004; 13: 111-116, 118.
51. Wang HW, Nie ZS, Duan YZ, Liu DD, Han ZH, Zhang XH and Hua B. Association between polymorphism in ACE gene with lung cancer and COPD patients (Chinese). 2000.
52. Zhang QZ, Liu XM, Zhang ZG and Wang LH. Analysis of the relationship between polymorphism of angiotensin-converting enzyme gene and lung cancer. Zhongguo Fei Ai Za Zhi 2005; 8: 211-214.
53. Zhang Y, He J, Deng Y, Zhang J, Li X, Xiang Z, Huang H, Tian C, Huang J and Fan H. The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis. BMC Med Genet 2011; 12: 159.
54. Mendoza J, Martinez J, Hernandez C, Perez-Montiel D, Castro C, Fabián-Morales E, Santibáñez M, González-Barrios R, Díaz-Chávez J, Andonegui MA, Reynoso N, Oñate LF, Jiménez MA, Núñez M, Dyer R, Herrera LA. Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 2004; 202: 330-335.
55. Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, Sakaguchi A and Kubota Y. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2003; 2: 1139-1147.
56. Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005; 26: 271-279.
57. Wu J, Akaike T, Hayashida K, Miyamoto Y, Nakagawa T, Miyakawa K, Müller-Esterl W and Maeda H. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 2002; 98: 29-35.
58. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-460.